tiprankstipranks
Trending News
More News >
Otsuka Corporation (JP:4768)
:4768
Advertisement

Otsuka (4768) AI Stock Analysis

Compare
1 Followers

Top Page

JP:4768

Otsuka

(OTC:4768)

Rating:80Outperform
Price Target:
¥3,743.00
▲(19.97% Upside)
Otsuka's strong financial performance and reasonable valuation contribute positively to its overall score. Technical analysis suggests positive momentum, although caution is advised due to overbought signals. The recent decline in operating cash flow warrants monitoring.

Otsuka (4768) vs. iShares MSCI Japan ETF (EWJ)

Otsuka Business Overview & Revenue Model

Company DescriptionOtsuka Corporation provides system integration, support, and other services in Japan. The System Integration Business segment offers system services, including consulting, system design and development, transport and installation work, and network construction. It also provides management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks. In addition, this segment sells computers, copiers, and communications equipment and software; and develops consigned software. The Service and Support Business segment offers supplies, hardware and software maintenance, telephone support, and outsourcing services; emergency computer rescue services for corporate and individual clients; and network support and services for the planning, design, construction, and operation of corporate information systems, as well as out-sources system engineers. It also provides educational support services. The company was founded in 1961 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyOtsuka Holdings makes money primarily through its pharmaceuticals and nutraceuticals divisions. The pharmaceutical segment generates revenue from the development and sale of prescription medications, with a strong focus on treatments for mental health conditions, cancer, and cardiovascular diseases. This includes globally recognized products such as antipsychotic drugs and oncology treatments. The nutraceutical segment contributes to earnings through the sale of nutritional drinks, supplements, and other health-related consumer products. Strategic partnerships and collaborations with other pharmaceutical companies and research institutions also play a crucial role in enhancing product development and expanding market reach, thereby contributing to the company's financial performance.

Otsuka Financial Statement Overview

Summary
Otsuka has demonstrated strong revenue growth and profitability, with a healthy gross profit margin and solid operational management. The balance sheet is robust, with low leverage and high liquidity. However, the recent decline in operating cash flow suggests potential pressures on cash generation.
Income Statement
85
Very Positive
Otsuka has demonstrated strong revenue growth, with a significant increase in total revenue over the past year. The gross profit margin is healthy, indicating efficient cost management. Net profit margin and EBIT margin show solid profitability, reflecting effective operational management. However, the recent decrease in operating cash flow raises some concerns about future profitability sustainability.
Balance Sheet
88
Very Positive
The company maintains a strong balance sheet with a solid equity ratio, suggesting a stable financial position. The debt-to-equity ratio is low, which indicates prudent use of leverage. Return on equity is robust, driven by consistent net income growth. The high level of cash and short-term investments enhances liquidity and financial flexibility.
Cash Flow
78
Positive
Otsuka's cash flow performance is generally positive, with consistent free cash flow generation. However, the notable decline in operating cash flow in the most recent TTM period could indicate potential pressures on cash generation. The free cash flow to net income ratio remains healthy, but the operating cash flow to net income ratio has weakened, suggesting a need for monitoring operational cash management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.11T977.37B861.02B851.89B836.32B
Gross Profit224.47B203.98B184.17B176.89B173.72B
EBITDA82.65B72.86B63.06B63.81B63.92B
Net Income53.48B47.45B40.02B39.93B39.31B
Balance Sheet
Total Assets673.90B561.80B523.02B486.25B471.29B
Cash, Cash Equivalents and Short-Term Investments228.14B228.69B202.29B204.70B178.07B
Total Debt6.86B7.30B7.51B7.99B8.02B
Total Liabilities298.66B214.85B200.29B184.48B191.26B
Stockholders Equity370.80B343.11B319.39B298.74B277.35B
Cash Flow
Free Cash Flow34.49B61.30B22.12B46.99B23.63B
Operating Cash Flow37.71B71.65B29.20B57.87B32.50B
Investing Cash Flow-11.95B-21.47B-8.36B-9.16B-8.72B
Financing Cash Flow-25.89B-23.84B-23.31B-21.96B-20.99B

Otsuka Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3120.00
Price Trends
50DMA
2921.88
Positive
100DMA
2971.66
Positive
200DMA
3203.55
Negative
Market Momentum
MACD
64.62
Negative
RSI
64.00
Neutral
STOCH
61.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4768, the sentiment is Positive. The current price of 3120 is above the 20-day moving average (MA) of 2939.55, above the 50-day MA of 2921.88, and below the 200-day MA of 3203.55, indicating a neutral trend. The MACD of 64.62 indicates Negative momentum. The RSI at 64.00 is Neutral, neither overbought nor oversold. The STOCH value of 61.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4768.

Otsuka Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$1.18T19.5017.11%3.85%20.18%23.93%
50
Neutral
C$3.26B5.38-49.37%9.08%2.09%-13.61%
€1.06B9.2011.40%
79
Outperform
¥290.07B9.55
2.95%21.63%659.16%
74
Outperform
¥73.76B10.79
3.02%7.56%12.07%
72
Outperform
¥55.42B9.05
1.94%11.02%65.67%
69
Neutral
¥96.47B20.41
1.29%6.08%19.69%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4768
Otsuka
3,120.00
-130.87
-4.03%
DE:9V2
Kaga Electronics Co., Ltd.
18.90
5.26
38.56%
JP:3107
Daiwabo Holdings Co., Ltd.
3,050.00
687.53
29.10%
JP:6638
Mimaki Engineering Co., Ltd.
1,879.00
449.30
31.43%
JP:7513
Kojima Co., Ltd.
1,251.00
206.03
19.72%
JP:9824
Senshu Electric Co., Ltd.
4,520.00
-185.01
-3.93%

Otsuka Corporate Events

Otsuka Corporation Reports Strong Financial Growth in First Half of 2025
Aug 1, 2025

Otsuka Corporation reported a significant increase in its financial performance for the first half of 2025, with net sales rising by 22% and operating profit by 26.6% compared to the previous year. This growth reflects the company’s strong market positioning and effective business strategies, signaling positive implications for stakeholders and reinforcing its competitive edge in the technology solutions industry.

The most recent analyst rating on (JP:4768) stock is a Hold with a Yen3500.00 price target. To see the full list of analyst forecasts on Otsuka stock, see the JP:4768 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 05, 2025